Healthcare Technology Report July 7, 2025

Wandercraft has raised $75 million in equity and debt to accelerate the launch of Eve, its self-balancing personal exoskeleton slated for 2026, expand clinical adoption of Atalante X, and advance industrial development of its humanoid robot, Calvin-40. The Series D round included participation from Renault Group, the French State-backed PSIM fund via Bpifrance,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Investments, Robotics/RPA, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article